| 1 |
33622325 | Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells. | 2021 Feb 23 |
1 |
| 2 |
34128573 | ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysis. | 2021 Sep |
2 |
| 3 |
30872116 | Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate. | 2019 Aug |
1 |
| 4 |
28987803 | Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation. | 2018 Feb |
1 |
| 5 |
29115880 | Treatment response heterogeneity in asthma: the role of genetic variation. | 2018 Jan |
1 |
| 6 |
29650006 | Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways. | 2018 Apr 12 |
1 |
| 7 |
29653961 | Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. | 2018 Jul |
1 |
| 8 |
29992699 | Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. | 2018 Nov |
1 |
| 9 |
30311516 | Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. | 2018 Oct |
1 |
| 10 |
27050801 | Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma. | 2016 Oct |
2 |
| 11 |
27452453 | Triple inhaled therapy for chronic obstructive pulmonary disease. | 2016 Nov |
1 |
| 12 |
27582089 | Vilanterol and fluticasone furoate for asthma. | 2016 Sep 1 |
1 |
| 13 |
25377687 | New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives. | 2015 May |
1 |
| 14 |
26676161 | Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol. | 2015 |
1 |
| 15 |
24621682 | Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. | 2014 Mar |
3 |
| 16 |
24641588 | Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. | 2014 Jul |
1 |
| 17 |
24279851 | Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting β2-agonists: results of the PACMAN cohort. | 2013 Dec |
2 |
| 18 |
22526864 | β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients. | 2012 Aug |
2 |
| 19 |
19430548 | Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. | 2009 Apr 30 |
2 |
| 20 |
17901197 | Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. | 2008 Jan |
1 |
| 21 |
18023995 | Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. | 2008 Feb |
1 |
| 22 |
18071293 | A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. | 2008 Mar |
1 |
| 23 |
18666664 | [Practice guideline 'Medical treatment of COPD']. | 2008 Jun 28 |
1 |
| 24 |
16872239 | Long-acting beta2-agonists in asthma: not so SMART? | 2006 |
1 |
| 25 |
14668964 | Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype. | 2004 Jan |
1 |
| 26 |
14524296 | [How to obtain complete control of asthma?]. | 2003 Jun |
2 |
| 27 |
14651722 | Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. | 2003 Nov |
1 |